Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Epidemiology

• Publication date

  2013-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/aje/kws200PMID 23171881PMCID PMC3590033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.

  2012cited by this paper
• High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer

  2011cited by this paper
• Cancer statistics, 2011

  2011cited by this paper
• Factors associated with Type I and Type II endometrial cancer

  2010cited by this paper
• Molecular Profiling of Endometrial Malignancies

  2010cited by this paper
• Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.

  2010cited by this paper
• Nonendometrioid endometrial carcinomas.

  2010cited by this paper
• Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort

  2010cited by this paper
• Role of Progesterone in Endometrial Cancer

  2010cited by this paper
• Management of early-stage endometrial cancer.

  2009cited by this paper
• Racial disparities for uterine corpus tumors

  2009cited by this paper
• Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes.

  2009cited by this paper
• Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition

  2009cited by this paper
• Family history of cancer and the risk of endometrial cancer

  2009cited by this paper
• BRCA Germline Mutations in Women With Uterine Serous Carcinoma-Still a Debate

  2009cited by this paper
• Racial disparities for uterine corpus tumors

  2009cited by this paper
• Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype

  2008cited by this paper
• Novel molecular profiles of endometrial cancer-new light through old windows.

  2008cited by this paper
• Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.

  2008cited by this paper
• Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)

  2008cited by this paper
• Ovarian cancer and hormone replacement therapy in the Million Women Study

  2007cited by this paper
• Lifetime Weight History and Endometrial Cancer Risk by Type of Menopausal Hormone Use in the NIH-AARP Diet and Health Study

  2007cited by this paper
• Clinicopathologic Analysis of 187 High-grade Endometrial Carcinomas of Different Histologic Subtypes: Similar Outcomes Belie Distinctive Biologic Differences

  2007cited by this paper
• Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study

  2007cited by this paper
• Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition

  2007cited by this paper
• Body size in relation to cancer of the uterine corpus in 1 million Norwegian women

  2007cited by this paper
• Usefulness of Body Mass Index as a Sufficient Adiposity Measurement for Sex Hormone Concentration Associations in Postmenopausal Women

  2006cited by this paper
• Recent developments and selected diagnostic problems in carcinomas of the endometrium.

  2005cited by this paper
• Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.

  2005cited by this paper
• Endometrial cancer and hormone-replacement therapy in the Million Women Study.

  2005cited by this paper
• Association between uterine serous carcinoma and breast cancer.

  2004cited by this paper
• Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women

  2004cited by this paper
• Prognostic parameters of endometrial carcinoma.

  2004cited by this paper
• Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

  2004cited by this paper
• Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus

  2003cited by this paper
• Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1

  2002cited by this paper
• Family history of breast cancer as a determinant of the risk of developing endometrial cancer: a nationwide cohort study

  2002cited by this paper
• Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.

  2002cited by this paper
• Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study.

  2001cited by this paper
• Re: Henderson,B.E. and Feigelson,H.S. (2000) hormonal carcinogenesis. Carcinogenesis, 21, 427-433.

  2001cited by this paper
• Hormonal interactions in endometrial cancer.

  2000cited by this paper
• Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach

  2000cited by this paper
• The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

  2000cited by this paper
• Hormonal carcinogenesis.

  2000cited by this paper
• Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.

  1999cited by this paper
• Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

  1998cited by this paper
• Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer.

  1997cited by this paper
• Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women.

  1997cited by this paper
• Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.

  1997cited by this paper
• Applying Cox regression to competing risks.

  1995cited by this paper
• Family history of breast, ovarian and endometrial cancer and risk of breast cancer.

  1993cited by this paper
• Two pathogenetic types of endometrial carcinoma.

  1983cited by this paper
• A case-control study of cancer of the endometrium.

  1982cited by this paper

• The role and effects of metabolic and bariatric surgery on endometrial cancer care.

  2026cites this paper
• Working in concert: radiology, pathology, and gynecologic oncology applications of the 2023 FIGO updates in endometrial cancer staging.

  2026cites this paper
• The implication of aberrant NRF2 activation in management of female cancers

  2025cites this paper
• Circulating miRNA as diagnostic tools for gynecological diseases and their applications in biosensor development

  2025influential citation
• Adiposity, metabolites and endometrial cancer risk: inference from combinations of Mendelian randomization and observational analyses

  2025cites this paper
• Clinical, Metabolic, and Sonographic Predictors of Endometrial Carcinoma Among Women Presenting With Postmenopausal Bleeding: A Prospective Observational Study From a Tertiary Care Center in South India

  2025cites this paper
• Ultra-processed food intake and risk of ovarian and endometrial cancer in the NIH-AARP cohort: a prospective cohort analysis: Ultra-processed food, ovarian & endometrial cancer.

  2025cites this paper
• Genetic polymorphism and current biotechnology approaches of therapeutic aspects within endometrial tumors

  2025cites this paper
• Disparities in hysterectomy-corrected endometrial cancer incidence trends by histologic subtype among racial/ethnic groups in California, 2012-2019.

  2025cites this paper
• Pubertal timing and incident uterine cancer in the Sister Study cohort.

  2025cites this paper
• Exploring the Potential Link between PFAS Exposure and Endometrial Cancer: A Review of Environmental and Sociodemographic Factors

  2024cites this paper
• A Prospective Observational Analysis of Endometrial Cancer Risk Associated with Thyroid Hormone Dysregulation

  2024cites this paper
• Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016-2019.

  2024cites this paper
• Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study

  2024cites this paper
• Adiposity, metabolites and endometrial cancer risk: Mendelian randomization and Observational analyses

  2024cites this paper
• Histopathological patterns of endometrial carcinoma in a tertiary hospital in North-West Nigeria

  2024cites this paper
• Molecular typing guiding treatment and prognosis of endometrial cancer

  2023cites this paper
• Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis.

  2023cites this paper
• Low-coverage whole-genome sequencing for the effective diagnosis of early endometrial cancer: A pilot study

  2023cites this paper
• CLINICO-EPIDEMIOLOGICAL FEATURES OF PATIENTS WITH ENDOMETRIAL CARCINOMA IN CLINICAL ONCOLOGY DEPARTMENT IN AIN SHAMS UNIVERSITY HOSPITALS IN EGYPT

  2023influential citation
• Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2).

  2023cites this paper
• Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis

  2023cites this paper
• Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients

  2023cites this paper
• A large multicenter propensity match study of sentinel lymph node biopsy feasibility in endometrioid variants of endometrial cancer.

  2022cites this paper
• The role of pregnancy in maternal cancer risk: Epidemiologic evidence from the Nordic Countries Linked Birth and Cancer Registries Cohort Project

  2022cites this paper
• Outdoor light at night and risk of endometrial cancer in the NIH-AARP diet and health study

  2022cites this paper
• Trend of uterine cancer at Hiwa Cancer Hospital of the Sulaymaniyah Province of Iraqi Kurdistan over a five-year period

  2022cites this paper
• Modifying effect of obesity on the content of sex hormones and their receptors in endometrial adenocarcinoma and its surrounding tissue

  2022cites this paper
• Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms

  2022cites this paper
• Tailored Therapy Based on Molecular Characteristics in Endometrial Cancer

  2021cites this paper
• Low-Coverage Whole Genome Sequencing Diagnoses Endometrial Carcinoma from Tampon DNA of Uterine Bleeding Patients

  2021cites this paper
• Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.

  2021cites this paper
• Statistical Meta-Analysis of Risk Factors for Endometrial Cancer and Development of a Risk Prediction Model Using an Artificial Neural Network Algorithm

  2021cites this paper
• A Danish nationwide study of risk factors associated with Type I and Type II endometrial cancer.

  2021cites this paper
• The value of new sonographic modalities, demographic, biometric and proliferative variables for the risk prediction in endometrial cancer

  2020cites this paper
• Associations of pregnancy‐related factors and birth characteristics with risk of endometrial cancer: A Nordic population‐based case–control study

  2020cites this paper
• Uterine Corpus Malignancies in Appalachia Kentucky: Incidence, Survival, and Related Health Disparities.

  2020cites this paper
• Pre-diagnosis health-related quality of life and survival in older women with endometrial cancer

  2020cites this paper
• Epigenetic alterations in female urogenital organs cancer: Premise, properties, and perspectives

  2020cites this paper
• LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration

  2020cites this paper
• Aspirin use and endometrial cancer risk: a meta-analysis and systematic review

  2020influential citation
• Excess Body Weight and Incidence of Type 1 and Type 2 Endometrial Cancer: The Norwegian Women and Cancer Study

  2020cites this paper
• Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

  2020cites this paper
• Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression

  2020cites this paper
• Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer

  2020cites this paper
• Consumption of Sweet Beverages and Cancer Risk. A Systematic Review and Meta-Analysis of Observational Studies

  2020cites this paper
• CLEP_A_253866 815..824

  2020cites this paper
• Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.

  2019cites this paper
• Absence of excess body fatness

  2019cites this paper
• Chronic Morbidity in Patients with Endometrial Cancer who Received Adjuvant Radiotherapy

  2019cites this paper
• Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes

  2019cites this paper
• Prognostic factors for rural endometrial cancer patients in a population-based cohort

  2019cites this paper
• Clinical actionability of molecular targets in endometrial cancer

  2019cites this paper
• Trend and Characteristics of Endometrial Cancer in Lagos, Nigeria.

  2019cites this paper
• Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway.

  2019cites this paper
• Uterine Corpus Cancer

  2018cites this paper
• Cancer Progress and Priorities: Uterine Cancer

  2018cites this paper
• Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study

  2018cites this paper
• Overexpression of the matrix metalloproteinase 11 gene is a potential biomarker for type 1 endometrial cancer.

  2018cites this paper
• Lifetime number of years of menstruation as a risk index for postmenopausal endometrial cancer in the Norwegian Women and Cancer Study

  2018cites this paper
• The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence

  2018cites this paper
• Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression

  2018cites this paper
• Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.

  2018cites this paper
• Preoperative Histopathological Grading and Clinical Staging Versus Surgico-Pathological Grading and Surgical Staging in Endometrial Carcinoma Patients: A Single Centre Retrospective Study

  2018cites this paper
• Role of Estrogen and Progesterone in Obesity Associated Gynecologic Cancers

  2018cites this paper
• Systems Epidemiology Approach in Endometrial Cancer. The NOWAC Study

  2018influential citation
• The association between histological subtype of a first primary endometrial cancer and second cancer risk

  2018cites this paper
• The incidence and pathogenetic types of multiple primary endometrial cancer in the Chelyabinsk region

  2018cites this paper
• Cadmium exposure and endometrial cancer risk: A large midwestern U.S. population-based case-control study

  2017cites this paper
• Les effets du régime méditerranéen sur les maladies chroniques: Maladies cardiovasculaires, stress oxydatif, dyslipidémie, diabète sucré, pression artérielle, cancer, maladies neurodégénératives et obésité.

  2017cites this paper
• Bokhman Redux: Endometrial cancer "types" in the 21st century.

  2017cites this paper
• Global Cancer in Women: Burden and Trends

  2017cites this paper
• Reproductive factors and incidence of endometrial cancer in U.S. black women

  2017cites this paper
• Time trends in the incidence of hysterectomy-corrected overall, type 1 and type 2 endometrial cancer in Denmark 1978-2014.

  2017cites this paper
• Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.

  2017cites this paper
• The effects of the Mediterranean Diet on Chronic Diseases: Cardiovascular Diseases, Oxidative Stress, Dyslipidemia, Diabetes Mellitus, Blood Pressure, Cancer, Neurodegenerative Disease and Obesity

  2017cites this paper
• Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women

  2016cites this paper
• Associations of Dietary Long-Chain ω-3 Polyunsaturated Fatty Acids and Fish Consumption With Endometrial Cancer Risk in the Black Women's Health Study.

  2016cites this paper
• Body Size, Metabolic Factors, and Risk of Endometrial Cancer in Black Women.

  2016cites this paper
• Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer

  2016cites this paper
• Childhood body mass index and height and risk of histologic subtypes of endometrial cancer

  2016cites this paper
• Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors

  2016cites this paper
• Biological relevance of decamethylcyclopentasiloxane (D5) induced rat uterine endometrial adenocarcinoma tumorigenesis: Mode of action and relevance to humans.

  2016cites this paper
• Diet, nutrition, and cancer: past, present and future

  2016cites this paper
• The influence of hormone therapies on type I and II endometrial cancer: A nationwide cohort study

  2016cites this paper
• Racial and Ethnic Differences in Endometrial Cancer

  2016cites this paper
• Family History and Risk of Endometrial Cancer: A Systematic Review and Meta-analysis

  2015cites this paper
• The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women

  2015cites this paper
• Mediator kinase module and human tumorigenesis

  2015cites this paper
• Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies.

  2015cites this paper
• Age at menarche and endometrial cancer risk: a dose-response meta-analysis of prospective studies

  2015cites this paper
• Obesity and the reproductive system disorders: epigenetics as a potential bridge.

  2015cites this paper
• A systematic review and meta-analysis of physical activity and endometrial cancer risk

  2015cites this paper
• Environmental (nongenetic) factors in gynecological cancers: update and future perspectives.

  2015cites this paper
• Environmental (nongenetic) factors in gynecological cancers: update and future perspectives.

  2015cites this paper
• Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER–Medicare Linked Database

  2015cites this paper
• Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies.

  2015cites this paper
• Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity

  2014cites this paper
• Genetics of endometrial cancer

  2014cites this paper
• Menopausal hormone therapy and risk of endometrial cancer.

  2014cites this paper